Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Journal of Alzheimer'S Disease : JAD|November 29, 2012
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM StudyAudrey Gabelle, Julien Dumurgier, Olivier Vercruysse, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 16, 2022
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letterMenglan Pang, Ling Zhu, Audrey Gabelle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2012
Intersite variability of CSF Alzheimer's disease biomarkers in clinical settingJulien Dumurgier, Olivier Vercruysse, Claire Paquet, et al.
Maturitas|June 6, 2020
Prospective associations between physical activity levels and white matter integrity in older adults: results from the MAPT studyMathieu Maltais, Yves Rolland, Katherine Boisvert-Vigneault, et al.
Alzheimer'S Research & Therapy|February 21, 2023
Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer's disease diagnosis in a memory clinic cohortChristophe Hirtz, Germain U Busto, Karim Bennys, et al.
Analytical Chemistry|November 16, 2019
In Vivo Large-Scale Mapping of Protein Turnover in Human Cerebrospinal FluidSylvain Lehmann, Christophe Hirtz, Jérôme Vialaret, et al.
Brain : a Journal of Neurology|February 16, 2013
C9orf72 repeat expansions are a rare genetic cause of parkinsonismSuzanne Lesage, Isabelle Le Ber, Christel Condroyer, et al.
Annals of Neurology|November 3, 2018
Reduced brain amyloid burden in elderly patients with narcolepsy type 1Audrey Gabelle, Isabelle Jaussent, Fayçal Ben Bouallègue, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related InflammationDimitri Renard, Anne Wacongne, Xavier Ayrignac, et al.
Annals of Clinical and Translational Neurology|August 3, 2021
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathologyChihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Journal of Alzheimer'S Disease : JAD|November 29, 2012
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM StudyAudrey Gabelle, Julien Dumurgier, Olivier Vercruysse, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 16, 2022
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letterMenglan Pang, Ling Zhu, Audrey Gabelle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2012
Intersite variability of CSF Alzheimer's disease biomarkers in clinical settingJulien Dumurgier, Olivier Vercruysse, Claire Paquet, et al.
Maturitas|June 6, 2020
Prospective associations between physical activity levels and white matter integrity in older adults: results from the MAPT studyMathieu Maltais, Yves Rolland, Katherine Boisvert-Vigneault, et al.
Alzheimer'S Research & Therapy|February 21, 2023
Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer's disease diagnosis in a memory clinic cohortChristophe Hirtz, Germain U Busto, Karim Bennys, et al.
Analytical Chemistry|November 16, 2019
In Vivo Large-Scale Mapping of Protein Turnover in Human Cerebrospinal FluidSylvain Lehmann, Christophe Hirtz, Jérôme Vialaret, et al.
Brain : a Journal of Neurology|February 16, 2013
C9orf72 repeat expansions are a rare genetic cause of parkinsonismSuzanne Lesage, Isabelle Le Ber, Christel Condroyer, et al.
Annals of Neurology|November 3, 2018
Reduced brain amyloid burden in elderly patients with narcolepsy type 1Audrey Gabelle, Isabelle Jaussent, Fayçal Ben Bouallègue, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related InflammationDimitri Renard, Anne Wacongne, Xavier Ayrignac, et al.
Annals of Clinical and Translational Neurology|August 3, 2021
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathologyChihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, et al.
Pageof 18